We serve Chemical Name:2-phenyl-1,3,5-triazine CAS:1722-18-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-phenyl-1,3,5-triazine
CAS.NO:1722-18-5
Synonyms:2-phenyl-sym-triazine;2-phenyl-s-triazine;2-phenyl-[1,3,5]triazine;Phenyl-[1,3,5]triazin;1,3,5-triazine,2-phenyl;phenyl-[1,3,5]triazine
Molecular Formula:C9H7N3
Molecular Weight:157.17200
HS Code:2933699090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:341.8ºC at 760 mmHg
Density:1.169 g/cm3
Index of Refraction:1.586
PSA:38.67000
Exact Mass:157.06400
LogP:1.53860
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2-phenyl-sym-triazine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,phenyl-[1,3,5]triazine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,3,5-triazine,2-phenyl Use and application,2-phenyl-s-triazine technical grade,usp/ep/jp grade.
Related News: The European Commission (EC) has approved MSD and Bayer’s Verquvo for the treatment of symptomatic chronic heart failure in patients with reduced ejection fraction. S(-)-3-[4-[2-(phenoxazin-10-yl)ethoxy]phenyl]-2-hydroxy propionic acid manufacturers According to Plexxikon, GSK scientists were only able to make Tafinlar after talks with Plexxikon about a potential partnership; although those talks never turned into a licensing deal, GSK apparently channeled that information and created a rival drug. Bis-(2-chloro-propyl)-(7-chloro-quinolin-4-yl)-amine; hydrochloride suppliers With rising demand and approvals required for new drugs, an external collaboration with CDMOs helps in driving a successful and robust clinical development plan for a new drug molecule. ethyl 1-butyl-5-(N-((4,6-dimethyl-1,3,5-triazin-2-yl)carbamoyl)sulfamoyl)-1H-pyrazole-4-carboxylate vendor & factory.